Prajapati et al.

European Quality of life (EuroQoL) and Short Form (SF)-36 have been designed

in an attempt to go beyond measurement of physical impairment and disability by

addressing more emotional and social aspect of a condition.

Short form-36 (Sf-36) –Short form -36 ( Eight Dimensions )

area

Dimension

No of Question

Functional status

Physical functioning

10

Social functioning

2

Physical problem

4

Emotional problem

3

Wellbeing

Mental health

5

Vitality

4

Pain

2

Overall evaluation

General health perception

5

Health change*

1

This item is not included in the eight dimensions nor is it scored

conclusion

The acceptance of any anti-rheumatoid arthritis drug in population is higher if the

drug is of lower in cost as well as higher in effect against disease and the anti-

rheumatoid arthritis effect is well shown by clinical outcomes via sign- symptom

and humanistic outcome is measured via HAQ and SF-36. So the ECHO model

is best to measure individual anti-rheumatoid arthritis drug effect on disease and

its cost involve in treatment. ECHO model also provides the easy way to compare

two different drugs or therapy regarding their cost and efficacy.

acknowledgement

The authors are grateful to the MPGI, Kanpur for providing the facilities and

support to complete the present work.

References

Agustin, E., Roy, W.H., Rincon, I.D. 2004 Measurement of global functional performance

in patient with rheumatoid arthritis using rheumatology function tests. Arthritis Res.

Ther. , 6 : R315-R325.

Arnett, F.C. et al . 1988 The American Rheumatoid Association 1987 revised criteria for

classification of rheumatoid arthritis. Arthritis Rheum ., 31 :315-324.

Bootman, J.L., Larson, L.N., McGhan, W.F., Townsend, R.J. 1989 Pharmaeconomic

research and clinical trial: concepts and issue. DICP Ann. Pharmacother ., 23 :693-697.

92

Int. J. Bioinformatics and Biological Sci.: v.2 n.1&2, p. 85-94. March & June 2014